311 related articles for article (PubMed ID: 18298555)
1. Management of stages I and II non-small-cell lung cancer in a New Zealand study: divergence from international practice and recommendations.
Stevens W; Stevens G; Kolbe J; Cox B
Intern Med J; 2008 Oct; 38(10):758-68. PubMed ID: 18298555
[TBL] [Abstract][Full Text] [Related]
2. Analysis of multidisciplinary lung cancer practice.
Conron M; Phuah S; Steinfort D; Dabscheck E; Wright G; Hart D
Intern Med J; 2007 Jan; 37(1):18-25. PubMed ID: 17199840
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer treatment in New Zealand: physician's attitudes.
Christmas T; Findlay M
N Z Med J; 2004 Jun; 117(1196):U931. PubMed ID: 15280935
[TBL] [Abstract][Full Text] [Related]
4. Population variations in the initial treatment of non-small-cell lung cancer.
Potosky AL; Saxman S; Wallace RB; Lynch CF
J Clin Oncol; 2004 Aug; 22(16):3261-8. PubMed ID: 15310770
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer in New Zealand: patterns of secondary care and implications for survival.
Stevens W; Stevens G; Kolbe J; Cox B
J Thorac Oncol; 2007 Jun; 2(6):481-93. PubMed ID: 17545842
[TBL] [Abstract][Full Text] [Related]
6. Regional differences in treatment and outcome in non-small cell lung cancer: a population-based study (Sweden).
Myrdal G; Lamberg K; Lambe M; Ståhle E; Wagenius G; Holmberg L
Lung Cancer; 2009 Jan; 63(1):16-22. PubMed ID: 18571760
[TBL] [Abstract][Full Text] [Related]
7. Auditing a new lung cancer service.
Cullen JP; Glynn C; Murtagh E; Hogan B; Jeffers M; Lane SJ
Ir Med J; 2004 Oct; 97(9):281-3. PubMed ID: 15568588
[TBL] [Abstract][Full Text] [Related]
8. Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group.
Richardson GE; Thursfield VJ; Giles GG
Med J Aust; 2000 Apr; 172(7):321-4. PubMed ID: 10844918
[TBL] [Abstract][Full Text] [Related]
9. Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: a prospective population-based study.
Wanders R; Steevens J; Botterweck A; Dingemans AM; Reymen B; Baardwijk Av; Borger J; Bootsma G; Pitz C; Lunde R; Geraedts W; Lambin P; De Ruysscher D
Eur J Cancer; 2011 Dec; 47(18):2691-7. PubMed ID: 21733675
[TBL] [Abstract][Full Text] [Related]
10. Temporal trends in the management of potentially resectable lung cancer.
Farjah F; Wood DE; Yanez D; Symons RG; Krishnadasan B; Flum DR
Ann Thorac Surg; 2008 Jun; 85(6):1850-5; discussion 1856. PubMed ID: 18498783
[TBL] [Abstract][Full Text] [Related]
11. Quality of integrated care for patients with nonsmall cell lung cancer: variations and determinants of care.
Ouwens MM; Hermens RR; Termeer RA; Vonk-Okhuijsen SY; Tjan-Heijnen VC; Verhagen AF; Hulscher MM; Marres HA; Wollersheim HC; Grol RP
Cancer; 2007 Oct; 110(8):1782-90. PubMed ID: 17724680
[TBL] [Abstract][Full Text] [Related]
12. [In which stage we diagnose and how we treat lung cancer?].
Oztuna F; Ozlü T; Bülbül Y
Tuberk Toraks; 2003; 51(2):152-6. PubMed ID: 15143421
[TBL] [Abstract][Full Text] [Related]
13. National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care.
Little AG; Gay EG; Gaspar LE; Stewart AK
Lung Cancer; 2007 Sep; 57(3):253-60. PubMed ID: 17451842
[TBL] [Abstract][Full Text] [Related]
14. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.
Steger V; Walles T; Kosan B; Walker T; Kyriss T; Veit S; Dippon J; Friedel G
Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576
[TBL] [Abstract][Full Text] [Related]
15. Comorbidity in older surgical cancer patients: influence on patient care and outcome.
Janssen-Heijnen ML; Maas HA; Houterman S; Lemmens VE; Rutten HJ; Coebergh JW
Eur J Cancer; 2007 Oct; 43(15):2179-93. PubMed ID: 17681780
[TBL] [Abstract][Full Text] [Related]
16. Results and impact of routine assessment of comorbidity in elderly patients with non-small-cell lung cancer aged > 80 years.
Breen D; Barlési F; Zemerli M; Doddoli C; Torre JP; Thomas P; Astoul P
Clin Lung Cancer; 2007 Mar; 8(5):331-4. PubMed ID: 17562233
[TBL] [Abstract][Full Text] [Related]
17. Effect of age on survival of clinical stage I non-small-cell lung cancer.
Sigel K; Bonomi M; Packer S; Wisnivesky J
Ann Surg Oncol; 2009 Jul; 16(7):1912-7. PubMed ID: 19408051
[TBL] [Abstract][Full Text] [Related]
18. Social inequalities in non-small cell lung cancer management and survival: a population-based study in central Sweden.
Berglund A; Holmberg L; Tishelman C; Wagenius G; Eaker S; Lambe M
Thorax; 2010 Apr; 65(4):327-33. PubMed ID: 20388758
[TBL] [Abstract][Full Text] [Related]
19. [Lung cancer in women: clinical features and factors related to survival].
Sen E; Kaya A; Erol S; Savas I; Gonullu U
Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]